OptiBiotix Health Plc (OPTI.L)
GBp 19.0
(-9.52%)
GBp 19.0
(-9.52%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -1.52 Million | -1.1 Million | -1.56 Million | -927.96 Thousand | -1.72 Million | -1.23 Million |
| Net Income | -2.03 Million | -2.48 Million | -1.36 Million | -1.11 Million | -2.36 Million | -1.91 Million |
| Depreciation & Amortization | 205 Thousand | 224 Thousand | 288.45 Thousand | 247.89 Thousand | 217.98 Thousand | 141.9 Thousand |
| Deferred income taxes | - | - | - | - | -787.92 Thousand | 161 Thousand |
| Stock-based compensation | 6000.00 | 11 Thousand | 60 Thousand | 127.24 Thousand | 126.75 Thousand | 128.22 Thousand |
| Change in working capital | -47 Thousand | 1.02 Million | -742.39 Thousand | -201.29 Thousand | -225.19 Thousand | -289.22 Thousand |
| Other non-cash items | 606 Thousand | 124 Thousand | 194.3 Thousand | 9582.00 | 1.31 Million | 543.82 Thousand |
| Investing Cash Flow | 1.11 Million | -331 Thousand | -193.5 Thousand | -350.34 Thousand | -594.92 Thousand | -470.59 Thousand |
| Investments in PPE | - | -168 Thousand | -193.5 Thousand | -350.34 Thousand | -594.92 Thousand | -2954.00 |
| Acquisitions | - | -188 Thousand | - | - | - | - |
| Investment purchases | - | 168 Thousand | - | - | - | - |
| Sales/Maturities of investments | 1.11 Million | 25 Thousand | 2.9 Million | - | - | - |
| Other Investing Activities | 1.11 Million | -168 Thousand | -2.9 Million | -350.34 Thousand | - | -467.63 Thousand |
| Financing Cash Flow | - | 485 Thousand | 2.9 Million | 1.68 Million | 1.44 Million | 1.78 Million |
| Debt repayment | - | - | - | - | -775.05 Thousand | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | 485 Thousand | - | 940.62 Thousand | 57.29 Thousand | 1.78 Million |
| Other Financing Activities | - | 485 Thousand | 2.9 Million | 746.75 Thousand | 617.13 Thousand | 1.78 Million |
| Accounts receivables | 61 Thousand | 1.11 Million | -906.66 Thousand | -37.19 Thousand | -233.5 Thousand | -267.68 Thousand |
| Accounts payables | -98 Thousand | -19 Thousand | 81.91 Thousand | -42.63 Thousand | 40.63 Thousand | 281.59 Thousand |
| Inventory | -10 Thousand | -76 Thousand | 82.35 Thousand | -121.47 Thousand | -32.32 Thousand | -21.54 Thousand |
| Other working capital | -98 Thousand | - | - | - | - | -281.59 Thousand |
| Cash at beginning of period | 1.05 Million | 2 Million | 864.68 Thousand | 455.6 Thousand | 1.32 Million | 1.24 Million |
| Cash at end of period | 635 Thousand | 1.05 Million | 2 Million | 864.68 Thousand | 455.6 Thousand | 1.32 Million |
| Capital Expenditure | - | -168 Thousand | -193.5 Thousand | -350.34 Thousand | -594.92 Thousand | -2954.00 |
| Effect of forex changes on cash | - | - | -1.00 | - | -455.6 Thousand | - |
| Net cash flow / Change in cash | -417 Thousand | -955 Thousand | 1.14 Million | 409.07 Thousand | -868.69 Thousand | 76.87 Thousand |
| Free Cash Flow | -1.52 Million | -1.27 Million | -1.75 Million | -1.27 Million | -2.31 Million | -1.23 Million |
| Breakdown | 2024 Q2 | 2023 Q4 | 2023 FY | 2023 Q2 | 2022 Q4 | 2022 FY |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -2.79 Million | -193 Thousand | -2.03 Million | -1.84 Million | -11.32 Million | -2.48 Million |
| Depreciation & Amortization | 106 Thousand | 113 Thousand | 205 Thousand | 93 Thousand | 106.57 Thousand | 224 Thousand |
| Deferred income taxes | - | - | - | - | 391.41 Thousand | - |
| Stock-based compensation | - | 6000.00 | 6000.00 | - | 5000.00 | 11 Thousand |
| Change in working capital | 130 Thousand | 196 Thousand | -47 Thousand | 91 Thousand | 609.75 Thousand | 1.02 Million |
| Other non-cash items | 1.81 Million | -1.06 Million | 606 Thousand | 1.17 Million | 9.52 Million | 124 Thousand |
| Investing Cash Flow | 89 Thousand | 683 Thousand | 1.11 Million | 427 Thousand | -238.07 Thousand | -331 Thousand |
| Investments in PPE | - | 15 Thousand | - | -15 Thousand | -110.27 Thousand | -168 Thousand |
| Acquisitions | - | - | - | - | -152.79 Thousand | -188 Thousand |
| Investment purchases | - | - | - | - | 238.07 Thousand | 168 Thousand |
| Sales/Maturities of investments | 89 Thousand | 668 Thousand | 1.11 Million | 442 Thousand | 25 Thousand | 25 Thousand |
| Other Investing Activities | - | 683 Thousand | 1.11 Million | 427 Thousand | -238 Thousand | -168 Thousand |
| Financing Cash Flow | 1.28 Million | - | - | - | 476 Thousand | 485 Thousand |
| Debt repayment | - | - | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 1.28 Million | - | - | - | 476 Thousand | 485 Thousand |
| Other Financing Activities | - | - | - | - | 476 Thousand | 485 Thousand |
| Accounts receivables | 67 Thousand | 205 Thousand | 61 Thousand | -144 Thousand | 457.77 Thousand | 1.11 Million |
| Accounts payables | 133 Thousand | -334 Thousand | -98 Thousand | 236 Thousand | 192.23 Thousand | -19 Thousand |
| Inventory | -70 Thousand | -9000.00 | -10 Thousand | -1000.00 | -40.25 Thousand | -76 Thousand |
| Other working capital | - | - | - | - | - | - |
| Cash at beginning of period | 635 Thousand | 893 Thousand | 1.05 Million | 1.05 Million | 1.5 Million | 2 Million |
| Cash at end of period | 1.26 Million | 635 Thousand | 635 Thousand | 893 Thousand | 1.05 Million | 1.05 Million |
| Capital Expenditure | - | 15 Thousand | - | -15 Thousand | -110.27 Thousand | -168 Thousand |
| Effect of forex changes on cash | - | - | - | - | -1.05 Million | - |
| Net cash flow / Change in cash | 628 Thousand | -258 Thousand | -417 Thousand | -159 Thousand | -457.34 Thousand | -955 Thousand |
| Free Cash Flow | -745 Thousand | -926 Thousand | -1.52 Million | -601 Thousand | -805.1 Thousand | -1.27 Million |
PRS
600227
5186
NNBR
FBK
AOT